{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T06:11:22Z","timestamp":1657692682636},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cll.2016.09.003","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T08:00:44Z","timestamp":1478937644000},"page":"xi-xx","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug Testing and Toxicology: Redefining the Plague of Darkness"],"prefix":"10.1016","volume":"36","author":[{"given":"Martin H.","family":"Bluth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2016.09.003_bib1","unstructured":"Exodus 10:21\u201329."},{"key":"10.1016\/j.cll.2016.09.003_bib2","unstructured":"Available at: https:\/\/www.govtrack.us\/congress\/bills\/109\/hr1020\/text\/ih. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/0033-2909.131.2.202","article-title":"Why does social exclusion hurt? The relationship between social and physical pain","volume":"131","author":"Macdonald","year":"2005","journal-title":"Psychol Bull"},{"key":"10.1016\/j.cll.2016.09.003_bib4","series-title":"A\u00a0nation in pain","author":"Foreman","year":"2014"},{"key":"10.1016\/j.cll.2016.09.003_bib5","series-title":"A\u00a0Blueprint for Transforming Prevention, Care, Education, and Research. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education","author":"Relieving Pain in America","year":"2011"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2016.09.003_bib6","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/bja\/aeq323","article-title":"When does acute pain become chronic?","volume":"105","author":"Voscopoulus","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cll.2016.09.003_bib7","year":"2011"},{"key":"10.1016\/j.cll.2016.09.003_bib8","first-page":"1","article-title":"How prevalent is chronic pain?","volume":"XI","author":"Harstall","year":"2003","journal-title":"IASP Pain Clin Updates"},{"key":"10.1016\/j.cll.2016.09.003_bib9","first-page":"769","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cll.2016.09.003_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2040622315627801","article-title":"Opioid-induced constipation: advances and clinical guidance","volume":"7","author":"Nelson","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.cll.2016.09.003_bib11","unstructured":"Kroll D. OIC is different: the drug behind the Super Bowl 50 constipation ad. 2016. Available at: Forbes.com. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib12","article-title":"Foods with fake health benefits","author":"Shockey","year":"2011","journal-title":"Village Voice."},{"key":"10.1016\/j.cll.2016.09.003_bib13","unstructured":"Stromberg J. It's a myth: there's no evidence that coffee stunts kids' growth. 2013. Available at: SMITHSONIAN.COM. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/bja\/87.1.144","article-title":"Role of psychology in pain management","volume":"87","author":"Eccleston","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cll.2016.09.003_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/AJP.0b013e31814b1afa","article-title":"Multivariate analysis of chronic pain patients undergoing lidocaine infusions: increasing pain severity and advancing age predict likelihood of clinically meaningful analgesia","volume":"23","author":"Carroll","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cll.2016.09.003_bib16","first-page":"11","article-title":"Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy","volume":"4","author":"Li","year":"2011","journal-title":"Pharmacogenomics Pers Med"},{"key":"10.1016\/j.cll.2016.09.003_bib17","first-page":"103","article-title":"Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges","volume":"14","author":"Bruehl","year":"2013","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cll.2016.09.003_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pain.2009.07.013","article-title":"Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment","volume":"146","author":"Walter","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.cll.2016.09.003_bib19","unstructured":"Available at: http:\/\/www.dea.gov\/docs\/2015%20NDTA%20Report.pdf. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib20","unstructured":"Available at: http:\/\/www.deadiversion.usdoj.gov\/mtgs\/pharm_awareness\/conf_2013\/august_2013\/prevoznik.pdf. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib21","unstructured":"Available at: http:\/\/www.courtswv.gov\/supreme-court\/docs\/spring2015\/14-0144.pdf. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib22","unstructured":"Available at: http:\/\/www.legis.state.tx.us\/tlodocs\/81R\/billtext\/pdf\/SB00911I.pdf#navpanes=0. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib23","unstructured":"Available at: http:\/\/www.legis.ga.gov\/Legislation\/20152016\/145217.pdf. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib24","unstructured":"Available at: www.NAMSDL.org. Accessed April 1, 2016."},{"issue":"25","key":"10.1016\/j.cll.2016.09.003_bib25","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMp1204493","article-title":"Medication reconciliation for controlled substances\u2014an \u201cideal\u201d prescription-drug monitoring program","volume":"366","author":"Perrone","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.09.003_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bjoms.2013.03.017","article-title":"Toxicology screening in oral and maxillofacial trauma patients","volume":"51","author":"McAllister","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.cll.2016.09.003_bib27","first-page":"ES119","article-title":"Urine drug testing: current recommendations and best practices","volume":"15","author":"Owen","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.cll.2016.09.003_bib28","unstructured":"Chen PW. For new doctors, 8\u00a0minutes per patient. NY Times. May 30, 2013. Available at: http:\/\/well.blogs.nytimes.com\/2013\/05\/30\/for-new-doctors-8-minutes-per-patient\/. Accessed May 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-152-11-201006010-00004","article-title":"Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain","volume":"152","author":"Starrels","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cll.2016.09.003_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.36076\/ppj.2011\/14\/189","article-title":"Illicit drug use in the pain patient population decreases with continued drug testing","volume":"14","author":"Pesce","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.cll.2016.09.003_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/07347324.2012.718959","article-title":"Comparison of objective screening and self-report for alcohol and drug use in traumatically injured patients","volume":"30","author":"Sakai","year":"2012","journal-title":"Alcohol Treat Q"},{"key":"10.1016\/j.cll.2016.09.003_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1081\/JA-200049327","article-title":"Validity of adolescent self-report of substance use","volume":"40","author":"Williams","year":"2005","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.cll.2016.09.003_bib33","unstructured":"Available at: https:\/\/www.nationaldrugscreening.com\/show-blog.php?id=234. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib34","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.36076\/ppj.2008\/11\/S155","article-title":"Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.cll.2016.09.003_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/08897077.2015.1132293","article-title":"Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic non-cancer pain patients in safety net health care settings","volume":"37","author":"Ceasar","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.cll.2016.09.003_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5055\/jom.2007.0022","article-title":"Family physicians\u2019 proficiency in urine drug test interpretation","volume":"3","author":"Reisfield","year":"2007","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.cll.2016.09.003_bib37","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/321856","article-title":"Can we influence prescribing patterns?","volume":"33","author":"Sbarbaro","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2016.09.003_bib38","unstructured":"Available at: https:\/\/www.whitehouse.gov\/sites\/default\/files\/ondcp\/issues-content\/fars_report_october_2011.pdf. Accessed April 1, 2016."},{"key":"10.1016\/j.cll.2016.09.003_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jat\/24.7.543","article-title":"Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood","volume":"24","author":"Sklerov","year":"2000","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.cll.2016.09.003_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jat\/bkv137","article-title":"Analysis of parent synthetic cannabinoids in blood and urinary metabolites by liquid chromatography tandem mass spectrometry","volume":"40","author":"Knittel","year":"2016","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.cll.2016.09.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/33.1.1","article-title":"Normalization of urinary drug concentrations with specific gravity and creatinine","volume":"33","author":"Cone","year":"2009","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.cll.2016.09.003_bib42","unstructured":"Available at: www.samhsa.gov. Accessed April 1, 2016."}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T05:33:27Z","timestamp":1657690407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271216300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0272271216300804"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.09.003","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Testing and Toxicology: Redefining the Plague of Darkness","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}